Literature DB >> 28050365

Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience.

Shashir Wanjare1, Rajarshi Gupta2, Preeti Mehta3.   

Abstract

INTRODUCTION: Emergence of Candida species resistant to Amphotericin B and triazole has led to use of echinocandins, mostly caspofungin in the management of invasive candidiasis. There are some published reports of caspofungin resistance in Candida species yet no studies on caspofungin susceptibility pattern of Candida species exist in Indian setup. AIM: To carry out the antifungal susceptibility of Candida isolates against caspofungin.
MATERIALS AND METHODS: In a retrospective study at a tertiary care teaching hospital, 60 preserved Candida isolates from inpatients of invasive candidiasis obtained over a period of 6 months from January 2015 to June 2015 were subjected to antifungal susceptibility to caspofungin and the Minimum Inhibitory Concentrations (MICs) of Candida species to caspofungin were determined by Epsilometer test (E-test).
RESULTS: Thirty Candida albicans and 30 Non albicansCandida mainly Candida glabrata, Candida parapsilosis and Candida tropicalis were tested for caspofungin susceptibitity by E-test. Caspofungin resistance was detected in 6.67% Candida albicans isolates. Caspofungin resistance was not observed in Candida parapsilosis, Candida glabrata and Candida tropicalis. This shows that caspofungin resistance is still rare. Further elaborate studies with clinical correlation data are needed to detect prevalence of caspofungin resistance.
CONCLUSION: Emergence of resistance in our study warrants need of elaborate studies with clinical correlation data to detect prevalence of resistance to caspofungin. E-test method proved to be an easy and simple technique for testing susceptibility of Candida to caspofungin.

Entities:  

Keywords:  Anti-fungal susceptibility; E-test; Fluconazole

Year:  2016        PMID: 28050365      PMCID: PMC5198318          DOI: 10.7860/JCDR/2016/23731.8883

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.

Authors:  M A Pfaller; M Castanheira; S R Lockhart; A M Ahlquist; S A Messer; R N Jones
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

Review 3.  Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.

Authors:  Zeina A Kanafani; John R Perfect
Journal:  Clin Infect Dis       Date:  2008-01-01       Impact factor: 9.079

4.  India--diabetes capital of the world: now heading towards hypertension.

Authors:  Shashank R Joshi; Rakesh M Parikh
Journal:  J Assoc Physicians India       Date:  2007-05

5.  SWOT Analysis for Molecular Diagnostics: Strengths, Weaknesses, Opportunities, and Threats.

Authors:  Daniel H Farkas; David W Bernard
Journal:  Biotechnol Healthc       Date:  2004-05

6.  Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

Authors:  George R Thompson; Nathan P Wiederhold; Ana C Vallor; Nyria C Villareal; James S Lewis; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

7.  Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.

Authors:  Mikkel Krogh-Madsen; Maiken Cavling Arendrup; Lars Heslet; Jenny Dahl Knudsen
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

8.  Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.

Authors:  Maiken Cavling Arendrup; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

9.  Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study.

Authors:  P Badiee; A Alborzi
Journal:  Iran J Microbiol       Date:  2011-12

Review 10.  Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.

Authors:  Claudia Spampinato; Darío Leonardi
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more
  1 in total

1.  Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin.

Authors:  Keunsook K Lee; Karen Kubo; Jehan Abdelmoneim Abdelaziz; Iain Cunningham; Alessandra de Silva Dantas; Xiaolin Chen; Hiroki Okada; Yoshikazu Ohya; Neil A R Gow
Journal:  Cell Surf       Date:  2018-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.